-
Something wrong with this record ?
CDK11 is required for transcription of replication-dependent histone genes
P. Gajdušková, I. Ruiz de Los Mozos, M. Rájecký, M. Hluchý, J. Ule, D. Blazek,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
617837
European Research Council - International
FC001002
Medical Research Council - United Kingdom
FC001002
Wellcome Trust - United Kingdom
Wellcome Trust - United Kingdom
FC001002
Cancer Research UK - United Kingdom
NLK
ProQuest Central
from 2004-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2004-01-01 to 1 year ago
- MeSH
- Chromatin genetics metabolism MeSH
- Cyclin-Dependent Kinases genetics metabolism MeSH
- Phosphorylation MeSH
- Transcription, Genetic * MeSH
- Histones genetics metabolism MeSH
- Humans MeSH
- Apoptosis Regulatory Proteins genetics metabolism MeSH
- Calcium-Binding Proteins genetics metabolism MeSH
- Gene Expression Regulation MeSH
- DNA Replication MeSH
- RNA genetics metabolism MeSH
- S Phase MeSH
- Serine metabolism MeSH
- Binding Sites MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Replication-dependent histones (RDH) are required for packaging of newly synthetized DNA into nucleosomes during the S phase when their expression is highly upregulated. However, the mechanisms of this upregulation in metazoan cells remain poorly understood. Using iCLIP and ChIP-seq, we found that human cyclin-dependent kinase 11 (CDK11) associates with RNA and chromatin of RDH genes primarily in the S phase. Moreover, its amino-terminal region binds FLASH, an RDH-specific 3'-end processing factor, which keeps the kinase on the chromatin. CDK11 phosphorylates serine 2 (Ser2) of the carboxy-terminal domain of RNA polymerase II (RNAPII), which is initiated when RNAPII reaches the middle of RDH genes and is required for further RNAPII elongation and 3'-end processing. CDK11 depletion leads to decreased number of cells in S phase, likely owing to the function of CDK11 in RDH gene expression. Thus, the reliance of RDH expression on CDK11 could explain why CDK11 is essential for the growth of many cancers.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028219
- 003
- CZ-PrNML
- 005
- 20210114153243.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41594-020-0406-8 $2 doi
- 035 __
- $a (PubMed)32367068
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gajdušková, Pavla $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
- 245 10
- $a CDK11 is required for transcription of replication-dependent histone genes / $c P. Gajdušková, I. Ruiz de Los Mozos, M. Rájecký, M. Hluchý, J. Ule, D. Blazek,
- 520 9_
- $a Replication-dependent histones (RDH) are required for packaging of newly synthetized DNA into nucleosomes during the S phase when their expression is highly upregulated. However, the mechanisms of this upregulation in metazoan cells remain poorly understood. Using iCLIP and ChIP-seq, we found that human cyclin-dependent kinase 11 (CDK11) associates with RNA and chromatin of RDH genes primarily in the S phase. Moreover, its amino-terminal region binds FLASH, an RDH-specific 3'-end processing factor, which keeps the kinase on the chromatin. CDK11 phosphorylates serine 2 (Ser2) of the carboxy-terminal domain of RNA polymerase II (RNAPII), which is initiated when RNAPII reaches the middle of RDH genes and is required for further RNAPII elongation and 3'-end processing. CDK11 depletion leads to decreased number of cells in S phase, likely owing to the function of CDK11 in RDH gene expression. Thus, the reliance of RDH expression on CDK11 could explain why CDK11 is essential for the growth of many cancers.
- 650 _2
- $a proteiny regulující apoptózu $x genetika $x metabolismus $7 D051017
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a proteiny vázající vápník $x genetika $x metabolismus $7 D002135
- 650 _2
- $a chromatin $x genetika $x metabolismus $7 D002843
- 650 _2
- $a cyklin-dependentní kinasy $x genetika $x metabolismus $7 D018844
- 650 _2
- $a replikace DNA $7 D004261
- 650 _2
- $a regulace genové exprese $7 D005786
- 650 _2
- $a histony $x genetika $x metabolismus $7 D006657
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a RNA $x genetika $x metabolismus $7 D012313
- 650 _2
- $a S fáze $7 D016196
- 650 _2
- $a serin $x metabolismus $7 D012694
- 650 12
- $a genetická transkripce $7 D014158
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ruiz de Los Mozos, Igor $u The Francis Crick Institute, London, UK. Department of Neuromuscular Disease, Institute of Neurology, University College London, London, UK.
- 700 1_
- $a Rájecký, Michal $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Hluchý, Milan $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Ule, Jernej $u The Francis Crick Institute, London, UK. Department of Neuromuscular Disease, Institute of Neurology, University College London, London, UK.
- 700 1_
- $a Blazek, Dalibor $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic. dalibor.blazek@ceitec.muni.cz.
- 773 0_
- $w MED00007513 $t Nature structural & molecular biology $x 1545-9985 $g Roč. 27, č. 5 (2020), s. 500-510
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32367068 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114153240 $b ABA008
- 999 __
- $a ok $b bmc $g 1608554 $s 1119399
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 27 $c 5 $d 500-510 $e 20200504 $i 1545-9985 $m Nature structural & molecular biology $n Nat Struct Mol Biol $x MED00007513
- GRA __
- $a 617837 $p European Research Council $2 International
- GRA __
- $a FC001002 $p Medical Research Council $2 United Kingdom
- GRA __
- $a FC001002 $p Wellcome Trust $2 United Kingdom
- GRA __
- $p Wellcome Trust $2 United Kingdom
- GRA __
- $a FC001002 $p Cancer Research UK $2 United Kingdom
- LZP __
- $a Pubmed-20210105